Deborah K. Mcmahon
Distinguished in HIV/AIDS

Dr. Deborah K. Mcmahon

Infectious Disease
UPMC
Center For Care Of Infectious Diseases (Ccid)
3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
On Staff At
Accepting New Patients

Distinguished in HIV/AIDS
UPMC
Center For Care Of Infectious Diseases (Ccid)
3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Deborah McMahon, MD, is certified in internal medicine and infectious disease by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Infectious Disease and is affiliated with UPMC Presbyterian. She completed her fellowship at University of Pittsburgh School of Medicine, residency at Maimonides Medical Center, and medical degree at Temple University School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule.

Dr. Mcmahon is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Sepsis, Myelitis, and AIDS Dementia Complex.

Her clinical research consists of co-authoring 67 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 47 articles and participated in 2 clinical trials in the study of HIV/AIDS.

Specialties
Infectious Disease
Licenses
Specialist in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
University of Pittsburgh School of Medicine
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

CENTER FOR CARE OF INFECTIOUS DISEASES (CCID)
3601 5th Avenue, Suite 700, Pittsburgh, PA 15213
Call: 412-530-6772

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2025
Intervention Type: Biological
Study Drug: Trimer 4571 vaccine
Study Phase: Phase 1
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
Enrollment Status: Completed
Publish Date: October 29, 2025
Intervention Type: Biological
Study Drugs: a1DC + inactivated whole autologous HIV, a1DC + conserved HIV peptides, a1DC + no antigen, pgDC + inactivated whole autologous HIV, pgDC + conserved HIV peptides, pgDC + no antigena1DC
Study Phase: Phase 1
A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of Q-Griffithsin Enema Administered Rectally to HIV-1 Seronegative Adults
A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of Q-Griffithsin Enema Administered Rectally to HIV-1 Seronegative Adults
Enrollment Status: Terminated
Publish Date: July 06, 2023
Intervention Type: Drug, Other
Study Phase: Phase 1
APT-POCT-01: An Open Label, Pharmacokinetic Study of Plasma/Urine/Salivary Drug Concentrations Over Fourteen Days Following Drug Intake Cessation, In HIV-Uninfected Healthy Volunteers Dosing to Steady-state to Further Development of Point of Care Diagnostic Testing
APT-POCT-01: An Open Label, Pharmacokinetic Study of Plasma/Urine/Salivary Drug Concentrations Over Fourteen Days Following Drug Intake Cessation, In HIV-Uninfected Healthy Volunteers Dosing to Steady-state to Further Development of Point of Care Diagnostic Testing
Enrollment Status: Completed
Publish Date: March 03, 2022
Intervention Type: Drug
Study Drugs: Dolutegravir, Emtricitabine/Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, Lamivudine
Study Phase: Early Phase 1
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

67 Total Publications

Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles.
Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles.
Journal: Science translational medicine
Published: September 17, 2025
View All 67 Publications
Similar Doctors
Elite in HIV/AIDS
Dr. John W. Mellors
Infectious Disease
Elite in HIV/AIDS
Dr. John W. Mellors
Infectious Disease

University Of Pittsburgh Physicians, Department Of Medicine, Division Of Infectious Disease

3601 5th Avenue, Falk Clinic Suite 700, 
Pittsburgh, PA 
 (0.1 miles away)
412-946-2738
Languages Spoken:
English, French
See accepted insurances

John Mellors, MD, specializes in infectious diseases and is board-certified in infectious disease and internal medicine by the American Board of Internal Medicine. He is affiliated with UPMC Presbyterian. Dr. Mellors received his medical degree from Dartmouth College Geisel School of Medicine and completed his residency and fellowship at Yale New Haven Hospital. Dr. Mellors is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

Bernard J. Macatangay
Distinguished in HIV/AIDS
Dr. Bernard J. Macatangay
Infectious Disease
Distinguished in HIV/AIDS
Dr. Bernard J. Macatangay
Infectious Disease

Division Of Infectious Diseases/ HIV/AIDS Program

3550 Fifth Avenue, Scaife Hall S827, 
Pittsburgh, PA 
 (2.2 miles away)
412-383-1272
Languages Spoken:
English, Filipino
See accepted insurances

Bernard Macatangay is an Infectious Disease provider in Pittsburgh, Pennsylvania. Dr. Macatangay is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

Sharon A. Riddler
Distinguished in HIV/AIDS
Dr. Sharon A. Riddler
Infectious Disease
Distinguished in HIV/AIDS
Dr. Sharon A. Riddler
Infectious Disease

Center For Care Of Infectious Diseases (Ccid)

3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
 (0.1 miles away)
412-438-2347
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sharon Riddler, MD, is certified in infectious disease and internal medicine by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Infectious Disease and is affiliated with UPMC Magee-Womens Hospital, and UPMC Presbyterian. She completed her fellowship at University of Pittsburgh School of Medicine, residency at University of Missouri Kansas City, and medical degree at Medical College of Wisconsin. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Riddler is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Sepsis, Myelitis, and AIDS Dementia Complex.

VIEW MORE HIV/AIDS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mcmahon's expertise for a condition
ConditionClose
    • Distinguished
    • HIV/AIDS
      Dr. Mcmahon is
      Distinguished
      . Learn about HIV/AIDS.
      See more HIV/AIDS experts
    • Sepsis
      Dr. Mcmahon is
      Distinguished
      . Learn about Sepsis.
      See more Sepsis experts
    • Advanced
    • AIDS Dementia Complex
      Dr. Mcmahon is
      Advanced
      . Learn about AIDS Dementia Complex.
      See more AIDS Dementia Complex experts
    • AIDS Dysmorphic Syndrome
      Dr. Mcmahon is
      Advanced
      . Learn about AIDS Dysmorphic Syndrome.
      See more AIDS Dysmorphic Syndrome experts
    • Myelitis
      Dr. Mcmahon is
      Advanced
      . Learn about Myelitis.
      See more Myelitis experts
    • Experienced
    • COVID-19
      Dr. Mcmahon is
      Experienced
      . Learn about COVID-19.
      See more COVID-19 experts
    • Emphysema
      Dr. Mcmahon is
      Experienced
      . Learn about Emphysema.
      See more Emphysema experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.